BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11748202)

  • 1. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS.
    Krall R; Sun J; Pederson KJ; Barbieri JT
    Infect Immun; 2002 Jan; 70(1):360-7. PubMed ID: 11748202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor.
    Sun J; Barbieri JT
    J Biol Chem; 2004 Oct; 279(41):42936-44. PubMed ID: 15292224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    Goehring UM; Schmidt G; Pederson KJ; Aktories K; Barbieri JT
    J Biol Chem; 1999 Dec; 274(51):36369-72. PubMed ID: 10593930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins.
    Pederson KJ; Krall R; Riese MJ; Barbieri JT
    Mol Microbiol; 2002 Dec; 46(5):1381-90. PubMed ID: 12453223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Pederson KJ; Vallis AJ; Aktories K; Frank DW; Barbieri JT
    Mol Microbiol; 1999 Apr; 32(2):393-401. PubMed ID: 10231494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa ExoT acts in vivo as a GTPase-activating protein for RhoA, Rac1, and Cdc42.
    Kazmierczak BI; Engel JN
    Infect Immun; 2002 Apr; 70(4):2198-205. PubMed ID: 11895987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS.
    Maresso AW; Baldwin MR; Barbieri JT
    J Biol Chem; 2004 Sep; 279(37):38402-8. PubMed ID: 15252013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S.
    Maresso AW; Riese MJ; Barbieri JT
    Biochemistry; 2003 Dec; 42(48):14249-57. PubMed ID: 14640693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.
    Henriksson ML; Sundin C; Jansson AL; Forsberg A; Palmer RH; Hallberg B
    Biochem J; 2002 Nov; 367(Pt 3):617-28. PubMed ID: 12132999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.
    Maresso AW; Deng Q; Pereckas MS; Wakim BT; Barbieri JT
    Cell Microbiol; 2007 Jan; 9(1):97-105. PubMed ID: 16889625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS.
    Riese MJ; Goehring UM; Ehrmantraut ME; Moss J; Barbieri JT; Aktories K; Schmidt G
    J Biol Chem; 2002 Apr; 277(14):12082-8. PubMed ID: 11821389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells.
    Pederson KJ; Pal S; Vallis AJ; Frank DW; Barbieri JT
    Mol Microbiol; 2000 Jul; 37(2):287-99. PubMed ID: 10931325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin.
    Barbieri JT
    Int J Med Microbiol; 2000 Oct; 290(4-5):381-7. PubMed ID: 11111915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS.
    Maresso AW; Barbieri JT
    Protein Expr Purif; 2002 Dec; 26(3):432-7. PubMed ID: 12460767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoform-specific roles of the GTPase activating protein Nadrin in cytoskeletal reorganization of platelets.
    Beck S; Fotinos A; Lang F; Gawaz M; Elvers M
    Cell Signal; 2013 Jan; 25(1):236-46. PubMed ID: 22975681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa ExoS and ExoT.
    Barbieri JT; Sun J
    Rev Physiol Biochem Pharmacol; 2004; 152():79-92. PubMed ID: 15375697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS.
    Zhang Y; Deng Q; Porath JA; Williams CL; Pederson-Gulrud KJ; Barbieri JT
    Cell Microbiol; 2007 Sep; 9(9):2192-201. PubMed ID: 17490406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells.
    Krall R; Zhang Y; Barbieri JT
    J Biol Chem; 2004 Jan; 279(4):2747-53. PubMed ID: 14597627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles.
    Zhang Y; Deng Q; Barbieri JT
    J Biol Chem; 2007 Apr; 282(17):13022-32. PubMed ID: 17311921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.